GAO Adulteration Report Points To Disconnect Among FDA Offices
This article was originally published in The Tan Sheet
Executive Summary
Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.
You may also be interested in...
Supplement Industry Must Step Up As Adulteration Threat Grows – FDA
The supplement industry has not done enough to aid FDA in pursuing firms adulterating products with drugs or getting the message out about adulteration, the agency says. Increased vigilance is needed especially as bad actors become more sophisticated and expand their adulteration activities.
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.